Torrent Pharmaceuticals Ltd., incorporated in the year 1972, is a Large Cap company (having a market cap of Rs 48651.53 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 1976.00 Crore, down -1.35 % from last quarter Total Income of Rs 2003.00 Crore and up .76 % from last year same quarter Total Income of Rs 1961.00 Crore. Company reported net profit after tax of Rs 324.00 Crore in latest quarter.
Investment Rationale
The brokerage continues to value TRP at 25x 12-month forward earnings and arrive at price target of INR2,530. It expects 14% earnings CAGR, led by 11%/17%/8%/11% CAGR in DF/US/Brazil/Germany sales, partially impacted by 70bp margin contraction, with normalization in opex related to its sales force in the DF segment. The current valuation captures upside in earnings over next two years adequately. Hence, it maintains Neutral rating on the stock.
Promoter/FII Holdings
Promoters held 71.3 per cent stake in the company as of March 31, 2021, while FIIs held 11.4 per cent, DIIs 8.4 per cent and public and others 9 per cent.
(Views and recommendations given in this section are the analysts’ own and do not represent those of ETMarkets.com. Please consult your financial adviser before taking any position in the stock/s mentioned.)
